Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Operative technique and pitfalls in donor heart procurement.

Shudo Y, Hiesinger W, Oyer PE, Woo YJ.

Asian Cardiovasc Thorac Ann. 2017 Jan;25(1):80-82. doi: 10.1177/0218492316678716. Epub 2016 Nov 12.

PMID:
28074702
2.

Influence of durable mechanical circulatory support and allosensitization on mortality after heart transplantation.

Chiu P, Schaffer JM, Oyer PE, Pham M, Banerjee D, Joseph Woo Y, Ha R.

J Heart Lung Transplant. 2016 Jun;35(6):731-42. doi: 10.1016/j.healun.2015.12.023. Epub 2016 Jan 7.

3.

A novel, catheter-based approach to left ventricular assist device deactivation after myocardial recovery.

Zeigler SM, Sheikh AY, Lee PH, Desai J, Banerjee D, Oyer P, Dake MD, Ha RV.

Ann Thorac Surg. 2014 Aug;98(2):710-3. doi: 10.1016/j.athoracsur.2013.09.073.

PMID:
25087798
4.

Response to letter regarding article entitled "Heart and combined heart–kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure".

Schaffer JM, Chiu P, Singh SK, Oyer PE, Reitz BA, Mallidi HR.

Am J Transplant. 2014 Aug;14(8):1948-9. No abstract available.

5.

Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?

Schaffer JM, Chiu P, Singh SK, Oyer PE, Reitz BA, Mallidi HR.

Am J Transplant. 2014 Mar;14(3):647-59. doi: 10.1111/ajt.12595. Epub 2014 Feb 12.

6.

Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure.

Schaffer JM, Chiu P, Singh SK, Oyer PE, Reitz BA, Mallidi HR.

Am J Transplant. 2014 Feb;14(2):384-96. doi: 10.1111/ajt.12522. Epub 2013 Nov 26.

7.

Heart transplant graft survival is improved after a reduction in panel reactive antibody activity.

Schaffer JM, Singh SK, Reitz BA, Oyer PE, Robbins RC, Mallidi HR.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):555-64; discussion 564-5. doi: 10.1016/j.jtcvs.2012.10.025. Epub 2012 Dec 13. Erratum in: J Thorac Cardiovasc Surg. 2013 May;145(5):1419.

8.

Late profound muscle weakness following heart transplantation due to Danon disease.

Van Der Starre P, Deuse T, Pritts C, Brun C, Vogel H, Oyer P.

Muscle Nerve. 2013 Jan;47(1):135-7. doi: 10.1002/mus.23517. Epub 2012 Nov 21.

PMID:
23168931
9.

Ventricular assist devices: history, patient selection, and timing of therapy.

Tang DG, Oyer PE, Mallidi HR.

J Cardiovasc Transl Res. 2009 Jun;2(2):159-67. doi: 10.1007/s12265-009-9098-5. Epub 2009 Mar 19. Review.

PMID:
20559983
10.

Changing trends in infectious disease in heart transplantation.

Haddad F, Deuse T, Pham M, Khazanie P, Rosso F, Luikart H, Valantine H, Leon S, Vu TA, Hunt SA, Oyer P, Montoya JG.

J Heart Lung Transplant. 2010 Mar;29(3):306-15. doi: 10.1016/j.healun.2009.08.018. Epub 2009 Oct 22.

PMID:
19853478
11.

Trends in invasive disease due to Candida species following heart and lung transplantation.

Schaenman JM, Rosso F, Austin JM, Baron EJ, Gamberg P, Miller J, Oyer PE, Robbins RC, Montoya JG.

Transpl Infect Dis. 2009 Apr;11(2):112-21. doi: 10.1111/j.1399-3062.2009.00364.x.

PMID:
19254327
12.

Twenty-year survivors of heart transplantation at Stanford University.

Deuse T, Haddad F, Pham M, Hunt S, Valantine H, Bates MJ, Mallidi HR, Oyer PE, Robbins RC, Reitz BA.

Am J Transplant. 2008 Sep;8(9):1769-74. doi: 10.1111/j.1600-6143.2008.02310.x. Epub 2008 Jun 12.

13.

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.

Kuppahally S, Al-Khaldi A, Weisshaar D, Valantine HA, Oyer P, Robbins RC, Hunt SA.

Am J Transplant. 2006 May;6(5 Pt 1):986-92.

14.

Outcome analysis of donor gender in heart transplantation.

Al-Khaldi A, Oyer PE, Robbins RC.

J Heart Lung Transplant. 2006 Apr;25(4):461-8. Epub 2006 Feb 28.

PMID:
16563978
15.

Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab.

Chin C, Pittson S, Luikart H, Bernstein D, Robbins R, Reitz B, Oyer P, Valantine H.

Transplantation. 2005 Aug 27;80(4):477-81.

PMID:
16123721
16.

Acute type A aortic dissection complicated by aortic regurgitation: composite valve graft versus separate valve graft versus conservative valve repair.

Lai DT, Miller DC, Mitchell RS, Oyer PE, Moore KA, Robbins RC, Shumway NE, Reitz BA.

J Thorac Cardiovasc Surg. 2003 Dec;126(6):1978-86.

17.

The impact of brain death on survival after heart transplantation: time is of the essence.

Cantin B, Kwok BW, Chan MC, Valantine HA, Oyer PE, Robbins RC, Hunt SA.

Transplantation. 2003 Nov 15;76(9):1275-9.

PMID:
14627902
18.

Long-term results of heart transplantation in patients older than 60 years.

Demers P, Moffatt S, Oyer PE, Hunt SA, Reitz BA, Robbins RC.

J Thorac Cardiovasc Surg. 2003 Jul;126(1):224-31.

19.

Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.

Gao SZ, Chaparro SV, Perlroth M, Montoya JG, Miller JL, DiMiceli S, Hastie T, Oyer PE, Schroeder J.

J Heart Lung Transplant. 2003 May;22(5):505-14.

PMID:
12742411
20.

Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation.

Pelletier MP, Coady M, Macha M, Oyer PE, Robbins RC.

J Heart Lung Transplant. 2003 Feb;22(2):124-9.

PMID:
12581759
21.

Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections?

Umaña JP, Lai DT, Mitchell RS, Moore KA, Rodriguez F, Robbins RC, Oyer PE, Dake MD, Shumway NE, Reitz BA, Miller DC.

J Thorac Cardiovasc Surg. 2002 Nov;124(5):896-910.

22.

Does profound hypothermic circulatory arrest improve survival in patients with acute type a aortic dissection?

Lai DT, Robbins RC, Mitchell RS, Moore KA, Oyer PE, Shumway NE, Reitz BA, Miller DC.

Circulation. 2002 Sep 24;106(12 Suppl 1):I218-28.

PMID:
12354737
23.

The Novacor left ventricular assist system: clinical experience from the Novacor registry.

Dagenais F, Portner PM, Robbins RC, Oyer PE.

J Card Surg. 2001;16(4):267-71.

PMID:
11833699
24.
25.

Severe tricuspid regurgitation after heart transplantation.

Chan MC, Giannetti N, Kato T, Kornbluth M, Oyer P, Valantine HA, Robbins RC, Hunt SA.

J Heart Lung Transplant. 2001 Jul;20(7):709-17.

PMID:
11448795
26.

Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis.

Moon MR, Miller DC, Moore KA, Oyer PE, Mitchell RS, Robbins RC, Stinson EB, Shumway NE, Reitz BA.

Ann Thorac Surg. 2001 Apr;71(4):1164-71.

PMID:
11308154
27.

The totally implantable novacor left ventricular assist system.

Robbins RC, Kown MH, Portner PM, Oyer PE.

Ann Thorac Surg. 2001 Mar;71(3 Suppl):S162-5; discussion S183-4.

PMID:
11265853
28.

Posttransplantation lymphoproliferative disease in heart and heart-lung transplant recipients: thirty years experience at our hospital.

Chaparro S, Gao S, Perlroth M, Montoya J, Hastie T, Miller JL, Oyer PE, Schroeder J.

J Heart Lung Transplant. 2001 Feb;20(2):258. No abstract available.

PMID:
11250519
29.

Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation.

Pelletier MP, Coady M, Macha M, Oyer PE, Robbins RC.

J Heart Lung Transplant. 2001 Feb;20(2):152. No abstract available.

PMID:
11250214
30.

Improved outcomes with an implantable left ventricular assist system: a multicenter study.

Portner PM, Jansen PG, Oyer PE, Wheeldon DR, Ramasamy N.

Ann Thorac Surg. 2001 Jan;71(1):205-9.

PMID:
11216747
31.

Bridge to transplant with the Novacor left ventricular assist system.

Robbins RC, Oyer PE.

Ann Thorac Surg. 1999 Aug;68(2):695-7.

PMID:
10475473
32.

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, Stinson EB, Brown BW Jr, Merigan TC, Schroeder JS.

Circulation. 1999 Jul 6;100(1):61-6.

PMID:
10393682
33.

Thirty years of cardiac transplantation at Stanford university.

Robbins RC, Barlow CW, Oyer PE, Hunt SA, Miller JL, Reitz BA, Stinson EB, Shumway NE.

J Thorac Cardiovasc Surg. 1999 May;117(5):939-51.

34.

Composite valve graft versus separate aortic valve and ascending aortic replacement: is there still a role for the separate procedure?

Yun KL, Miller DC, Fann JI, Mitchell RS, Robbins RC, Moore KA, Oyer PE, Stinson EB, Shumway NE, Reitz BA.

Circulation. 1997 Nov 4;96(9 Suppl):II-368-75.

PMID:
9386126
35.

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis.

Reichenspurner H, Gamberg P, Nitschke M, Valantine H, Hunt S, Oyer PE, Reitz BA.

Transplant Proc. 1997 Feb-Mar;29(1-2):627-8. No abstract available.

PMID:
9123449
36.

Twenty-year clinical experience with porcine bioprostheses.

Fann JI, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE.

Ann Thorac Surg. 1996 Nov;62(5):1301-11; discussion 1311-2.

PMID:
8893561
37.

Heart-lung transplantation: Cardiac clinicopathological correlations.

Joshi A, Oyer PE, Berry GJ, Billingham ME.

Cardiovasc Pathol. 1996 May-Jun;5(3):153-8.

PMID:
25851477
38.

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria.

Haywood GA, Rickenbacher PR, Trindade PT, Gullestad L, Jiang JP, Schroeder JS, Vagelos R, Oyer P, Fowler MB.

Heart. 1996 May;75(5):455-62.

39.

Surgical management of aortic dissection during a 30-year period.

Fann JI, Smith JA, Miller DC, Mitchell RS, Moore KA, Grunkemeier G, Stinson EB, Oyer PE, Reitz BA, Shumway NE.

Circulation. 1995 Nov 1;92(9 Suppl):II113-21.

PMID:
7586393
40.

Heart retransplantation: the 25-year experience at a single institution.

Smith JA, Ribakove GH, Hunt SA, Miller J, Stinson EB, Oyer PE, Robbins RC, Shumway NE, Reitz BA.

J Heart Lung Transplant. 1995 Sep-Oct;14(5):832-9.

PMID:
8800717
41.

Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses.

Yun KL, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE.

Ann Thorac Surg. 1995 Aug;60(2 Suppl):S221-8.

PMID:
7646163
42.

Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.

Kuo PC, Luikart H, Busse-Henry S, Hunt SA, Valantine HA, Stinson EB, Oyer PE, Scandling JD, Alfrey EJ, Dafoe DC.

Clin Transplant. 1995 Apr;9(2):92-7.

PMID:
7599409
43.

Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Study overview. LVAS Study Group. Left Ventricular Assist System.

Pennington DG, Griffith BP, McKinlay SM, Oyer PE, Domanski MJ, Portner PM, Watson JT.

ASAIO J. 1995 Jan-Mar;41(1):11-5. Review.

PMID:
7727812
44.

Pediatric cardiac transplantation. The Stanford experience.

Sarris GE, Smith JA, Bernstein D, Griffin ML, Pitlick PT, Baum D, Billingham ME, Oyer PE, Stinson EB, Starnes VA, et al.

Circulation. 1994 Nov;90(5 Pt 2):II51-5.

PMID:
7955282
45.

Surgical management of aortic dissection in patients with the Marfan syndrome.

Smith JA, Fann JI, Miller DC, Moore KA, DeAnda A Jr, Mitchell RS, Stinson EB, Oyer PE, Reitz BA, Shumway NE.

Circulation. 1994 Nov;90(5 Pt 2):II235-42.

PMID:
7955259
46.

Long-term results of combined heart-lung transplantation: the Stanford experience.

Sarris GE, Smith JA, Shumway NE, Stinson EB, Oyer PE, Robbins RC, Billingham ME, Theodore J, Moore KA, Reitz BA.

J Heart Lung Transplant. 1994 Nov-Dec;13(6):940-9.

PMID:
7865527
47.

Cardiac transplantation: the Stanford experience in the cyclosporine era.

Sarris GE, Moore KA, Schroeder JS, Hunt SA, Fowler MB, Valantine HB, Vagelos RH, Billingham ME, Oyer PE, Stinson EB, et al.

J Thorac Cardiovasc Surg. 1994 Aug;108(2):240-51; discussion 251-2.

48.

Chylothorax complicating coronary artery by-pass grafting.

Smith JA, Goldstein J, Oyer PE.

J Cardiovasc Surg (Torino). 1994 Aug;35(4):307-9. Review.

PMID:
7929541
49.

Randomized, prospective assessment of bioprosthetic valve durability. Hancock versus Carpentier-Edwards valves.

Sarris GE, Robbins RC, Miller DC, Mitchell RS, Moore KA, Stinson EB, Oyer PE, Reitz BA, Shumway NE.

Circulation. 1993 Nov;88(5 Pt 2):II55-64.

PMID:
8222197
50.

Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation.

Keogh AM, Valantine HA, Hunt SA, Schroeder JS, McIntosh N, Oyer PE, Stinson EB.

J Heart Lung Transplant. 1992 Sep-Oct;11(5):892-901.

PMID:
1420237

Supplemental Content

Support Center